Catalyst

Slingshot members are tracking this event:

Endo Pharmaceuticals Launched Belbuca in the US for Chronic Pain Management

Source Link:
http://www.endo.com/news-events/press-releases

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ENDP
100%
BDSI
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details After being approved by the FDA in Fall 2015, Endo, in partnership with BioDelivery, has announced they have launched Belbuca for nationwide availability.
http://www.endo.com/...
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Feb 22, 2016
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Belbuca, Chronic Pain Management, Buprenorphine
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.